The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/38222
StudyName: Eligibility Breast Cancer NCT02053636
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 29.09.2019
License: Creative Commons BY 4.0

----

Description: 
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02053636
